Brookstone Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Brookstone Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-50,311	Closed	-$2.16M	–	473
2020 Q2	$2.16M	Sell	50,311 -17,865	-26%	-$738K	0.13%	113
2020 Q1	$2.46M	Buy	+68,176	New	+$2.91M	0.14%	99
2018 Q4	–	Sell	-53,552	Closed	-$2.6M	–	409
2018 Q3	$2.6M	Buy	+53,552	New	+$2.54M	0.2%	119
2015 Q4	–	Sell	-72	Closed	-$3K	–	892
2015 Q3	$3K	Sell	72 -178	-71%	-$10.7K	﹤0.01%	1630
2015 Q2	$16K	Buy	+250	New	+$15.6K	﹤0.01%	969

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Brookstone Capital Management's XPH Position: Q3 2020 in Review

Brookstone Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2020, closing a stake of 50,311 shares — an estimated $2.16M sold.

Brookstone Capital Management first reported a position in XPH in Q2 2015 and held it in 5 quarters. The position peaked at $2.6M in Q3 2018. 72 funds tracked by Wall St. Rank hold XPH as of Q3 2020.

Brookstone Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
Brookstone Capital Management sold 50,311 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2020, an estimated $2.16M.
Brookstone Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2015 and held it in 5 quarters.
Brookstone Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.6M in Q3 2018.
72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2020.

Based on Brookstone Capital Management's 13F filing for Q3 2020, filed 13 Oct 2020.